Stock Sanofi-Aventis underperforms European glamour stocks

Share Sanofi-Aventis among the losing European glamour stocks

The Sanofi-Aventis share now belongs to the worse performing glamour stocks in Europe. Over the past 12 months the mega cap is an impressive 26 percent lower. The European glamour stocks are 1 percent lower. Investors pay now 15 times the CAPE-ratio per share. The average European glamour stocks are traded at 28.

Over the current book year the total revenue will be 35,18 billion euros (consensus estimates). This is slightly lower than 2017's revenue of 36,2 billion euros.

Historical revenues and results Sanofi-Aventis plus estimates 2018

stock analysis

The analysts expect for 2018 a net profit of 6,75 billion euros. According to most of the analysts the company will have a profit per share for this book year of 5,46 euros. Based on this the price/earnings-ratio is 12,02.

Huge dividend Sanofi-Aventis

Per share the analysts anticipate on a dividend of 3,08 euros per share. Sanofi-Aventis 's dividend yield thus equals 4,69 percent. The average dividend yield of the pharmaceutical companies is a low 0,5 percent.

Newest target prices around 75 euros

The most recent recommendations for the pharmaceutical company are from Jefferies & Co., Sanford C. Bernstein & Co and Berenberg.

Sanofi-Aventis 's market value equals around 83,48 billion .

Historical stock prices Sanofi-Aventis

stock analysis sanofi-aventis

At 17.35 the stock trades 0,71 percent lower at 65,63 euros.

ValueSpectrum.com News Wire & Equity Research: +31 084-0032-842
news@valuespectrum.com

Copyright analist.nl B.V.
All rights reserved. Any redistribution, duplication or archiving prohibited. analist.nl doesn't warrant the accuracy of any News Content provided and shall not be liable for any errors, inaccuracies or for any actions taken in reliance thereon.